Publicacions en què col·labora amb MARTA MARIA GARCIA CLEMENTE (16)

2024

  1. Immunoglobulin genes and severity of COVID-19

    Immunogenetics, Vol. 76, Núm. 3, pp. 213-217

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Age-dependent effect of the IFIH1/MDA5 gene variants on the risk of critical COVID-19

    Immunogenetics, Vol. 75, Núm. 2, pp. 91-98

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. COVID-19 Associated Pulmonary Aspergillosis (CAPA): Hospital or Home Environment as a Source of Life-Threatening Aspergillus fumigatus Infection?

    Journal of Fungi, Vol. 8, Núm. 3

  3. FURIN gene variants (rs6224/rs4702) as potential markers of death and cardiovascular traits in severe COVID-19

    Journal of Medical Virology, Vol. 94, Núm. 8, pp. 3589-3595

  4. IGHG3 hinge length variation was associated with the risk of critical disease and death in a Spanish COVID-19 cohort

    Genes and Immunity, Vol. 23, Núm. 6, pp. 205-208

  5. The FCGR2A rs1801274 polymorphism was associated with the risk of death among COVID-19 patients

    Clinical Immunology, Vol. 236

  6. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2021

  1. DNA genotyping of the ABO gene showed a significant association of the A-group (A1/A2 variants) with severe COVID-19.

    European Journal of Internal Medicine

  2. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues

    Cell Reports, Vol. 37, Núm. 7

  3. The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19

    Cytokine, Vol. 137

  4. Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity

    International Immunopharmacology, Vol. 98

2020

  1. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome

    Gene, Vol. 762

2018

  1. High rates of tuberculin skin test positivity due to methotrexate therapy: False positive results?

    Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 3, pp. 538-546

2014

  1. T-cell profiling and the immunodiagnosis of latent tuberculosis infection in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases, Vol. 20, Núm. 2, pp. 329-338